NO20024590L - Farmasöytiske preparater inneholdende oligosakkarider, de nye oligosakkarider samt deres fremstilling - Google Patents
Farmasöytiske preparater inneholdende oligosakkarider, de nye oligosakkarider samt deres fremstillingInfo
- Publication number
- NO20024590L NO20024590L NO20024590A NO20024590A NO20024590L NO 20024590 L NO20024590 L NO 20024590L NO 20024590 A NO20024590 A NO 20024590A NO 20024590 A NO20024590 A NO 20024590A NO 20024590 L NO20024590 L NO 20024590L
- Authority
- NO
- Norway
- Prior art keywords
- oligosaccharides
- preparation
- pharmaceutical preparations
- new
- preparations containing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/02—Acyclic radicals, not substituted by cyclic structures
- C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
- C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
- C08B37/0078—Degradation products
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Physical Education & Sports Medicine (AREA)
- Molecular Biology (AREA)
- Cardiology (AREA)
- Biochemistry (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Heart & Thoracic Surgery (AREA)
- Crystallography & Structural Chemistry (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Polymers & Plastics (AREA)
- Communicable Diseases (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Materials Engineering (AREA)
- Oncology (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Dermatology (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0003910A FR2807043B1 (fr) | 2000-03-28 | 2000-03-28 | Composition pharmaceutique contenant des oligosaccharides, les nouveaux oligosaccharides et leur preparation |
PCT/FR2001/000903 WO2001072762A1 (fr) | 2000-03-28 | 2001-03-26 | Compositions pharmaceutiques contenant des oligosaccharides et leur preparation |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20024590L true NO20024590L (no) | 2002-09-25 |
NO20024590D0 NO20024590D0 (no) | 2002-09-25 |
Family
ID=8848572
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20024590A NO20024590D0 (no) | 2000-03-28 | 2002-09-25 | Farmasöytiske preparater inneholdende oligosakkarider, de nye oligosakkarider samt deres fremstilling |
Country Status (27)
Country | Link |
---|---|
EP (1) | EP1272499B1 (et) |
JP (1) | JP2003529570A (et) |
KR (1) | KR20030001394A (et) |
CN (1) | CN1183149C (et) |
AR (1) | AR034251A1 (et) |
AT (1) | ATE290543T1 (et) |
AU (1) | AU782713B2 (et) |
BR (1) | BR0109617A (et) |
CA (1) | CA2403906A1 (et) |
DE (1) | DE60109279T2 (et) |
EA (1) | EA004768B1 (et) |
EE (1) | EE200200551A (et) |
ES (1) | ES2236206T3 (et) |
FR (1) | FR2807043B1 (et) |
HK (1) | HK1056564A1 (et) |
HU (1) | HUP0300330A3 (et) |
IL (1) | IL151832A0 (et) |
ME (1) | MEP88408A (et) |
MX (1) | MXPA02009455A (et) |
NO (1) | NO20024590D0 (et) |
NZ (1) | NZ521558A (et) |
PL (1) | PL204419B1 (et) |
PT (1) | PT1272499E (et) |
SK (1) | SK286745B6 (et) |
WO (1) | WO2001072762A1 (et) |
YU (1) | YU72802A (et) |
ZA (1) | ZA200207707B (et) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6750207B1 (en) * | 1992-05-01 | 2004-06-15 | Yeda Research And Development Co. Ltd. | Compositions for the regulation of cytokine activity |
FR2845686B1 (fr) * | 2002-10-10 | 2013-08-30 | Aventis Pharma Sa | Melanges de polysaccharides derives d'heparine, leur preparation et les compositions pharmaceutiques les contenant |
US7511026B2 (en) * | 2003-03-25 | 2009-03-31 | Seikagaku Corporation | Therapeutic agent for nerve damage |
FR2857971B1 (fr) * | 2003-07-24 | 2005-08-26 | Aventis Pharma Sa | Melanges d'oligosaccharides derives d'heparine, leur preparation et les compositions pharmaceutiques les contenant |
US20050186679A1 (en) * | 2004-02-24 | 2005-08-25 | Christian Viskov | Method for determining specific groups constituting heparins or low molecular weight heparins |
JP5116071B2 (ja) | 2005-07-20 | 2013-01-09 | 帝國製薬株式会社 | D−アロースおよびd−プシコースの抗神経因性疼痛効果の利用 |
US8211899B2 (en) | 2005-08-30 | 2012-07-03 | Inter-University Research Institute Corporation National Institute Of Natural Sciences | Artificial nucleic acid bases and their use in base pairing natural nucleic acid bases |
EP3418287A1 (en) * | 2017-06-21 | 2018-12-26 | Universität für Bodenkultur Wien | Chemical release of asparaginelinked glycans |
CN115317507A (zh) * | 2022-09-19 | 2022-11-11 | 中国科学院海洋研究所 | 低分子量褐藻多糖硫酸酯在制备抗多动症药物中的应用 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5449688A (en) * | 1993-03-30 | 1995-09-12 | The United States Of America As Represented By The Department Of Health And Human Services | Method of treating chronic inflammatory diseases |
-
2000
- 2000-03-28 FR FR0003910A patent/FR2807043B1/fr not_active Expired - Fee Related
-
2001
- 2001-03-26 DE DE60109279T patent/DE60109279T2/de not_active Expired - Fee Related
- 2001-03-26 IL IL15183201A patent/IL151832A0/xx unknown
- 2001-03-26 ES ES01919561T patent/ES2236206T3/es not_active Expired - Lifetime
- 2001-03-26 BR BR0109617-6A patent/BR0109617A/pt not_active IP Right Cessation
- 2001-03-26 EE EEP200200551A patent/EE200200551A/et unknown
- 2001-03-26 CN CNB018084087A patent/CN1183149C/zh not_active Expired - Fee Related
- 2001-03-26 EP EP01919561A patent/EP1272499B1/fr not_active Expired - Lifetime
- 2001-03-26 PL PL357301A patent/PL204419B1/pl unknown
- 2001-03-26 EA EA200201024A patent/EA004768B1/ru not_active IP Right Cessation
- 2001-03-26 HU HU0300330A patent/HUP0300330A3/hu unknown
- 2001-03-26 CA CA002403906A patent/CA2403906A1/fr not_active Abandoned
- 2001-03-26 KR KR1020027012867A patent/KR20030001394A/ko not_active Application Discontinuation
- 2001-03-26 AU AU46639/01A patent/AU782713B2/en not_active Ceased
- 2001-03-26 MX MXPA02009455A patent/MXPA02009455A/es active IP Right Grant
- 2001-03-26 SK SK1393-2002A patent/SK286745B6/sk not_active IP Right Cessation
- 2001-03-26 JP JP2001570671A patent/JP2003529570A/ja active Pending
- 2001-03-26 ME MEP-884/08A patent/MEP88408A/xx unknown
- 2001-03-26 AT AT01919561T patent/ATE290543T1/de not_active IP Right Cessation
- 2001-03-26 WO PCT/FR2001/000903 patent/WO2001072762A1/fr not_active Application Discontinuation
- 2001-03-26 YU YU72802A patent/YU72802A/sh unknown
- 2001-03-26 PT PT01919561T patent/PT1272499E/pt unknown
- 2001-03-26 NZ NZ521558A patent/NZ521558A/en not_active IP Right Cessation
- 2001-03-27 AR ARP010101456A patent/AR034251A1/es unknown
-
2002
- 2002-09-25 NO NO20024590A patent/NO20024590D0/no unknown
- 2002-09-25 ZA ZA200207707A patent/ZA200207707B/en unknown
-
2003
- 2003-11-26 HK HK03108634A patent/HK1056564A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20032187L (no) | Heterocyklylalkylpiperidinderivater, deres fremstilling samt preparater inneholdende forbindelsene | |
NO982580D0 (no) | Nye taxoider, deres fremstilling samt farmas°ystiske preparater inneholdende taxoidene | |
NO20024176L (no) | Farmasöytiske preparater inneholder derivater av 3-amino- azetidin, de nye derivater og deres fremstilling | |
NO20024175D0 (no) | Azetidinderivater, deres fremstilling og farmasöytiske forbindelser inneholdende de samme | |
NO20010013D0 (no) | Svovelsubstituerte sulfonylaminokarboksylsyre N-arylamider, deres fremstilling og anvendelse samt farmasöytiske preparater inneholdende forbindelsene | |
NO20032438D0 (no) | Orto- og metasubstituerte bis-arylforbindelser, deres fremstilling og anvendelse samt farmasöytiske preparater inneholdende forbindelsene | |
NL1015859A1 (nl) | Farmaceutische preparaten. | |
NO20030296L (no) | Heparinavledede polysakkaridblandinger, deres fremstilling samt farmasöytiske preparater inneholdende blandingene | |
NO20005146L (no) | Tienylazolylalkoksyetanaminer, deres fremstilling og deres anvendelse som medikamenter | |
NO992102L (no) | Peptidblanding, samt farmasøytisk sammensetning og kreftvaksine som innbefatter peptidblandingen | |
NO20023400L (no) | Nye forbindelser med hypolidemisk og hypokolesteremisk virkning, deres fremstilling samt preparater inneholdendeforbindelsene | |
DK1098874T3 (da) | Benzocycloheptener, fremgangsmåder til deres fremstilling, farmaceutiske præparater, som indeholder disse, samt deres anvendelse til fremstilling af lægemidler | |
NO20022021D0 (no) | Indeno-, nafto- og benzocyklohepta-dihydrotiazolderivater, fremstilling av de samme og deres anvendelse somanoreksilegemidler | |
NO995745D0 (no) | Nye derivater av erytromycin, fremgangsmåte for fremstilling av disse, samt deres anvendelse som medikamenter | |
NO20016247L (no) | Streptograminderivater, deres fremstilling samt preparater inneholdende derivatene | |
NO20041773L (no) | Farmasoytiske preparater for reduksjon av cellers aktivitet samt deres anvendelse. | |
NO20003661D0 (no) | Nye pentasakkarider, fremgangsmÕter for deres fremstilling og farmasøytiske preparater inneholdende de samme | |
NO20024590L (no) | Farmasöytiske preparater inneholdende oligosakkarider, de nye oligosakkarider samt deres fremstilling | |
DK1118610T3 (da) | Benzensulfonamid-derivater, fremgangsmåde til fremstilling heraf samt farmaceutiske sammensætninger indeholdende derivaterne | |
NO983472D0 (no) | Taxoider, deres fremstilling og farmas°ytiske preparater inneholdende taxoidene | |
PT1228039E (pt) | N-guanidinoalquilamidas sua preparacao sua utilizacao e preparacoes farmaceuticas contendo as mesmas | |
NO20035163D0 (no) | Nye piperidinkarboksamid-derivater, fremgangsmåte for deres fremstilling ogfarmasöytiske preparater inneholdende de samme | |
DK199900435U3 (da) | Farmaceutisk præparat omfattende paroxetin-methansulfonat samt anvendelse heraf | |
NO20014692D0 (no) | 3-amidinobenzensulfonamidderivater, medisinske sammensetninger inneholdende slike samt intermediater vedfremstillingen derav | |
NO985171D0 (no) | Sulfonamidsubstituerte kondenserte 5-ringforbindelser, deres anvendelse som medikament samt farmas°ytiske preparater inneholdende forbindelsene |